TY - JOUR
T1 - Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder
T2 - Acute outcomes
AU - Rohan, Kelly J.
AU - Mahon, Jennifer N.
AU - Evans, Maggie
AU - Ho, Sheau Yan
AU - Meyerhoff, Jonah
AU - Postolache, Teodor T.
AU - Vacek, Pamela M.
N1 - Publisher Copyright:
© 2015, American Psychiatric Association. All rights reserved.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Objective: Whereas considerable evidence supports light therapy for winter seasonal affective disorder (SAD), data on cognitive- behavioral therapy for SAD (CBT-SAD) are promising but preliminary. This study estimated the difference between CBT-SAD and light therapy outcomes in a large, more definitive test. Method: The participants were 177 adults with a current episode of major depression that was recurrent with a seasonal pattern. The randomized clinical trial compared 6 weeks of CBT-SAD (N=88) and light therapy (N=89). Light therapy consisted of 10,000-lux cool-white florescent light, initiated at 30 minutes each morning and adjusted according to a treatment algorithm based on response and side effects. CBT-SAD comprised 12 sessions of the authors' SAD-tailored protocol in a group format and was administered by Ph.D. psychologists in two 90-minute sessions per week. Outcomes were continuous scores on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and after treatment) and posttreatment remission status based on cut points. Results: Depression severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SAD and light therapy. Having a baseline comorbid diagnosis was associated with higher depression scores across all time points in both treatments. CBT-SAD and light therapy did not differ in remission rates based on the SIGH-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%). Conclusions: CBT-SAD and light therapy are comparably effective for SAD during an acute episode, and both may be considered as treatment options.
AB - Objective: Whereas considerable evidence supports light therapy for winter seasonal affective disorder (SAD), data on cognitive- behavioral therapy for SAD (CBT-SAD) are promising but preliminary. This study estimated the difference between CBT-SAD and light therapy outcomes in a large, more definitive test. Method: The participants were 177 adults with a current episode of major depression that was recurrent with a seasonal pattern. The randomized clinical trial compared 6 weeks of CBT-SAD (N=88) and light therapy (N=89). Light therapy consisted of 10,000-lux cool-white florescent light, initiated at 30 minutes each morning and adjusted according to a treatment algorithm based on response and side effects. CBT-SAD comprised 12 sessions of the authors' SAD-tailored protocol in a group format and was administered by Ph.D. psychologists in two 90-minute sessions per week. Outcomes were continuous scores on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and after treatment) and posttreatment remission status based on cut points. Results: Depression severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SAD and light therapy. Having a baseline comorbid diagnosis was associated with higher depression scores across all time points in both treatments. CBT-SAD and light therapy did not differ in remission rates based on the SIGH-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%). Conclusions: CBT-SAD and light therapy are comparably effective for SAD during an acute episode, and both may be considered as treatment options.
UR - http://www.scopus.com/inward/record.url?scp=84933060555&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933060555&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.2015.14101293
DO - 10.1176/appi.ajp.2015.14101293
M3 - Article
C2 - 25859764
AN - SCOPUS:84933060555
SN - 0002-953X
VL - 172
SP - 862
EP - 869
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 9
ER -